IL9 and chronic myelogenous leukemia, BCR-ABL1 positive: Anti-IL-9 antibody-treated mice had a corresponding decrease in mRNA levels of cryptdin 1 and sPLA2 in the colon and ileum when compared to CML mice that received an isotype control antibody, as well as animals maintained on Tet (Fig. 2f, g).